- At: 2006 FIP Congress in Salvadore (Brazil)
- Type: Presentation
- By: CROMMELIN, Daan (Dutch Top Institute Pharma, Leiden, Netherlands)
The group of therapeutics proteins produced via recombinant or hybridoma technology (‘biologicals’) is growing fast. These (glyco)proteins differ in a number of aspects from low molecular weight drugs (1). They are all macromolecules folding their amino acid/sugar strands in complex secondary, tertiary and sometimes quaternary structures. These.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.